Depressive Disorder Clinical Trial
Official title:
Technology Enhanced Behavioral Activation Treatment for Substance Use
Verified date | January 2021 |
Source | University of North Carolina, Chapel Hill |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to: 1. test the effect of a smartphone enhanced LETS ACT (LETS ACT-SE) on frequency of substance use 2. use functional magnetic resonance imaging (fMRI) to test the relationship between neuromarkers of reward sensitivity on frequency of substance use.
Status | Completed |
Enrollment | 206 |
Est. completion date | December 2020 |
Est. primary completion date | December 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 55 Years |
Eligibility | Inclusion Criteria: - Between 18 and 55 - Meet criteria for DSM-V substance use disorder - Elevated depressive symptoms (BDI = 14) Exclusion Criteria: - Limited mental competency (MMSE < 23) - Psychosis - The use of psychotropic medication for < 3 months - The inability to give informed, voluntary, written consent to participate |
Country | Name | City | State |
---|---|---|---|
United States | University of North Carolina at Chapel Hill | Chapel Hill | North Carolina |
United States | Southlight Healthcare | Raleigh | North Carolina |
Lead Sponsor | Collaborator |
---|---|
University of North Carolina, Chapel Hill | National Institute on Drug Abuse (NIDA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Timeline Followback (TLFB) | The Time Line Follow Back is a self-report measure of drug and alcohol use. | TLFB will be assessed from baseline to a 12-month follow up period. | |
Secondary | Behavioral Activation for Depression Scale (BADS) | The BADS is a 25-item self-report measure of overall level of activity involvement | BADS will be assessed from baseline to a 12-month follow up period. | |
Secondary | Reward Probability Index (RPI) | The RPI is a 20-item self-report measure used to assess environmental reward and punishment. | RPI will be assessed from baseline to a 12-month follow up period. | |
Secondary | Beck Depression Inventory-II (BDI-II) | The Beck Depression Inventory is a 21-item self-report measure of depressive symptoms | BDI-II will be evaluated from baseline to a 12-month follow up period | |
Secondary | Daily Goals Form | The Daily Goals Form is used to measure Treatment Engagement. | Baseline to a 3-months post treatment. | |
Secondary | Texas Christian University (TCU) HIV/AIDS Risk Assessment Form | The TCU is a self-structured interview that measures HIV risk behavior in the domains of drug use and sex | TCU will be assessed from baseline to a 12-month follow up period. | |
Secondary | Urinalysis | Urinalysis is a biological measure of substance use. | Urinalysis is assessed from post treatment to a 12-month follow up period | |
Secondary | Breathalyzer | Breathalyzer is a biological measure of alcohol use. | Breathalyzer will be assessed from baseline to a 12-month follow up period. | |
Secondary | Short Form Health Survey (SF-12) | The SF-12 is a 12-item self-report measure of mental and physical health-related functioning. | SF-12 will be assessed from baseline to a 12-month follow up period. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01316926 -
Paxil CR Bioequivalence Study Brazil
|
Phase 1 | |
Recruiting |
NCT06187454 -
Transcranial Direct Current Stimulation for Depression
|
N/A | |
Completed |
NCT04469322 -
Pharmacogenetic Implementation Trial in Veterans With Treatment Refractory Depression
|
N/A | |
Recruiting |
NCT05768126 -
Prediction of ECT Treatment Response and Reduction of Cognitive Side-effects Using EEG and Rivastigmine
|
Phase 4 | |
Completed |
NCT03219879 -
Telephone-administered Relapse Prevention for Depression
|
N/A | |
Recruiting |
NCT06038721 -
Unified Protocol: Community Connections
|
N/A | |
Completed |
NCT03043560 -
Study to Treat Major Depressive Disorder With a New Medication
|
Phase 2 | |
Completed |
NCT04091139 -
Research of Unified Protocol for the Treatment of Common Mental Disorders in Adolescents in Hong Kong
|
Phase 2/Phase 3 | |
Completed |
NCT00069459 -
Seasonal Affective Depression (SAD) Study
|
Phase 1 | |
Recruiting |
NCT05503966 -
Combining Antidepressants and Attention Bias Modification in Depression
|
N/A | |
Recruiting |
NCT03001245 -
Interpersonal Counseling (IPC) for Treatment of Depression in Adolescents
|
N/A | |
Completed |
NCT02939560 -
TMS for Adults With Autism and Depression
|
N/A | |
Completed |
NCT02542891 -
European Comparative Effectiveness Research on Internet-based Depression Treatment
|
N/A | |
Completed |
NCT02452892 -
Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
|
N/A | |
Completed |
NCT02224508 -
Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks
|
N/A | |
Completed |
NCT02306551 -
Well Being And Resilience: Mechanisms of Transmission of Health and Risk
|
||
Withdrawn |
NCT02238730 -
Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive Therapy
|
N/A | |
Completed |
NCT01407575 -
Buprenorphine for Treatment Resistant Depression
|
Phase 3 | |
Completed |
NCT01597661 -
Bupropion & Cardio Birth Defect (Slone)
|
N/A | |
Completed |
NCT01093053 -
Mind-Body Skills Groups for the Treatment of War Zone Stress in Military and Veteran Populations
|
N/A |